Class of 2026
For foundational advances in deciphering how natural killer (NK) cells discriminate between healthy and abnormal cells, including the characterization of key activating and inhibitory receptors, their cognate ligands, and the signaling pathways that govern NK-cell activation, tolerance, and antitumor immunity.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]